P. Burgel (Sorbonne Paris Cité, France), P. Goeminne (Bornem, Belgium)
Late Breaking Abstract - COVID-19 epidemic in Respiratory Diseases Unit: partioning analysis and data mining. Results from a single Institution experience.
G. Stella (Pavia (PV), Italy), G. Accordino (Pavia (PV), Italy), A. Grosso (Pavia (PV), Italy), F. Albicini (Pavia (PV), Italy), E. Gini (Pavia (PV), Italy), S. Mancinelli (Pavia (PV), Italy), M. Della Zoppa (Pavia (PV), Italy), D. Piloni (Pavia (PV), Italy), A. Corsico (Pavia (PV), Italy)
|   |
Impact of PAHs exposure on exacerbation frequency in asthma using a new grid-scale simulation of PM2.5-PAHs distribution
T. Sheng (Taoyuan, Taiwan), Y. Huang (Taoyuan, Taiwan), S. Lee (Taoyuan, Taiwan), C. Lee (Kaohsiung, Taiwan), K. Chung (London, United Kingdom), C. Wang (Taoyuan, Taiwan)
| |
Prognostic value of right ventricular systolic dysfunction in patients with chronic obstructive pulmonary disease after ST-segment elevation myocardial infarction (STEMI).
K. Klester (Barnaul (Altay), Russian Federation), E. Klester (Barnaul (Altay), Russian Federation), A. Balitskaya (Barnaul (Altay), Russian Federation), A. Bocharova (Barnaul (Altay), Russian Federation), V. Elykomov (Barnaul (Altay), Russian Federation)
| |
Effect of COPD on immediate and long-term outcomes of STEMI.
A. Balitskya (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), . Weisman (Barnaul, Russian Federation)
| |
Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
T. Lapperre (Copenhagen, Denmark), U. Bodtger (Naestved, Denmark), D. Kjærsgaard Klein (Copenhagen, Denmark), L. Frøssing (Copenhagen, Denmark), M. Hvidtfeldt (Copenhagen, Denmark), A. Silberbrandt (Copenhagen, Denmark), N. Obling (Copenhagen, Denmark), L. Bjermer (Lund, Sweden), C. Porsbjerg (Copenhagen, Denmark)
| |
Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease?
R. Sprooten (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), K. Lenaerts (Maastricht, Netherlands), N. Reynaert (Maastricht, Netherlands), M. Groenen (Horn, Netherlands), F. Franssen (Horn, Netherlands)
| |
Preclinical myocardial dysfunction in healthy smokers and COPD patients
V. Nevzorova (Vladivostok (Primorsky Krai), Russian Federation), E. Kondrashova (Vladivostok (Primorsky Krai), Russian Federation), D. Kondrashov (Vladivostok (Primorsky Krai), Russian Federation)
| |
Inhaled steroids and prevalence of osteoporosis in chronic obstructive pulmonary disease: Data from the DACCORD cohort
F. Trudzinski (Heidelberg, Germany), C. Vogelmeier (Marburg, Germany), R. Buhl (Mainz, Germany), F. Trinkmann (Heidelberg, Germany), V. Obermoser (Nürnberg, Germany), P. Kardos (Frankfurt, Germany), C. Criée (Bovenden, Germany), H. Worth (Fürth, Germany)
| |
LSC - 2020 - Could the overweight influence bronchiectasis (B) exacerbations frequency (EF)?
K. Suska (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine)
| |
Can fractional exhaled nitric oxide be useful to differentiate asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from COPD-only
S. MOSTAFAVI POURMANSHADI (Montréal (QC), Canada), N. Naderi (Montréal (QC), Canada), P. Mancino (Montréal (QC), Canada), P. Li (Montréal (QC), Canada), W. Tan (Vancouver (BC), Canada), J. Bourbeau (Montréal (QC), Canada)
| |
The impact of previous pulmonary tuberculosis on lung cancer development in never smoker with COPD
H. Park (Seoul, Republic of Korea), S. Shin (Seoul, Republic of Korea), D. Kang (Seoul, Republic of Korea), H. Choi (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), J. Cho (Seoul, Republic of Korea)
| |
Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
S. Rodrigues Sousa (Coimbra, Portugal), J. Nunes Caldeira (Coimbra, Portugal), C. Rodrigues (Coimbra, Portugal), A. Figueiredo (Coimbra, Portugal), F. Barata (Coimbra, Portugal)
| |
Decreased pulmonary function tests are affected by blood glucose tolerance
K. Huang (Beijing, China), T. Yang (Beijing, China), G. Li (Beijing, China)
| |
Hyalyronic acid as marker of respiratory system remodelling
V. Fedotov (Nizhny Novgorod, Russian Federation), T. Blinova (Nizhny Novgorod, Russian Federation)
| |
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
C. Crimi (Catania (CT), Italy), G. Cacopardo (Catania (CT), Italy), S. Nolasco (Catania (CT), Italy), R. Campisi (Catania (CT), Italy), L. Spicuzza (Catania (CT), Italy), N. Crimi (Catania (CT), Italy)
| |
Influence of tobacco smoking on lipid peroxidation in exhaled breath condensate in asthma patients with exercise-induced bronchoconstriction (EIB)
J. Perelman (Blagoveshchensk (Amur Oblast), Russian Federation), L. Nakhamchen (Blagoveshchensk (Amur Oblast), Russian Federation), A. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation), E. Borodin (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
High healthcare utilisation and functional impairment in inducible laryngeal obstruction: results from the UK national registry
J. Haines (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Simpson (Hull, United Kingdom), J. Selby (London, United Kingdom), J. Hull (London, United Kingdom)
| |
HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
G. Cacopardo (Catania(CT), Italy), R. Campisi (Catania(CT), Italy), C. Crimi (Catania(CT), Italy), E. Heffler (Milano(MI), Italy), R. Intravaia (Catania(CT), Italy), S. Nolasco (Catania(CT), Italy), S. Ferri (Milano(MI), Italy), N. Crimi (Catania(CT), Italy)
| |